Drugs / Spersadex
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05433428 Background | Aug 2020 → Jan 2023 | cataract, dry eye syndrome | Ifocus Oyeklinikk | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Spersadex | “Spersadex 1 mg/ml 20 days after surgery” NCT05433428 ↗ |